Tebra Names Kevin Marasco as Chief Marketing Officer

SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.–(BUSINESS WIRE)–#EHR—Tebra, the digital backbone for independent healthcare practices, announced that Kevin Marasco has joined the company as Chief Marketing Officer. Kevin will lead the marketing team and report directly to CEO Dan Rodrigues. As CMO, he will lead all aspects … [Read more…]

Get more out of your training with the new HRM-Pro Plus from Garmin

Premium heart rate strap will now track pace and distance during indoor runs, giving athletes even more data to push their limits OLATHE, Kan.–(BUSINESS WIRE)–Garmin® International, Inc., a unit of Garmin Ltd. (NYSE: GRMN), today announced the HRM-Pro™ Plus, a premium heart rate strap that adds pace and distance data while continuing to provide athletes … [Read more…]

Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022

Webcast of Capital Markets Day on August 3 will include discussion of fiscal fourth-quarter results ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results the evening of August 2. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its capital markets … [Read more…]

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2022 financial results after the market close on Wednesday, August 3, 2022. The … [Read more…]

Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and LimaCorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, today announced a licensing partnership for the U.S. market to provide a novel solution for patients with the challenging condition of chronic high dislocation … [Read more…]

Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Orion to receive an upfront payment of USD 290 million Agreement strengthens and complements Merck’s oncology pipeline RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Orion Corporation (“Orion”) today announced a global development and commercialization agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 … [Read more…]

Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by 94% and 99% within 24 and 48 hours of treatment, respectively Median time to a negative PCR test was three days after beginning treatment in the nitric oxide group vs. seven days in the placebo group (P < 0.05) Participants … [Read more…]

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Expands bioanalytical services to include many emerging areas worldwide MALVERN, Pa.–(BUSINESS WIRE)–Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital … [Read more…]

Element Nutritional Sciences Announces Rejuvenate™ Immune Health Now Available Through Amazon.com

BURLINGTON, Ontario–(BUSINESS WIRE)–$ELMT—Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased to announce that its latest innovation, Rejuvenate™ Immune Health, is now available to consumers on the Amazon platform in the United States through the Company’s distribution partnership with e-commerce accelerator Pattern Inc. (“Pattern”). Rejuvenate™ Immune Health is a powdered drink … [Read more…]

Chemotherapy Induced Peripheral Neuropathy Market 2028: Increasing Prevalence of Cancer Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel” report has been added to ResearchAndMarkets.com’s offering. The chemotherapy-induced peripheral neuropathy market is expected to grow from US$ 813.48 million in 2021 to US$ 1,174.26 million by 2028; it is estimated to grow … [Read more…]